Skip to main content

Leuprolide News

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

FRIDAY, June 20, 2025 – Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published recently in JNCI:...

FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer

TAIPEI, May 26, 2021 /PRNewswire/ – Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for...

FDA Approves Fensolvi (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty

BUFFALO GROVE, Ill., May 4, 2020 /PRNewswire/ – Tolmar Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application for Fensolvi...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Prostate Cancer, Endometriosis, Breast Cancer - Adjuvant, Uterine Leiomyomata / Fibroids, Female Infertility

Related drug support groups

Lupron, Lupron Depot

Leuprolide patient information at Drugs.com